Stock Screener App

Gratuito -

Installare

12.75

13.26% -1.9499

Pre-mercato: 14.50 1.7499 +13.72%

Eloxx Pharmaceuticals Inc (ELOX)

Panoramica Notizia Cronologia dei prezzi Forum Previsione Frazionamento azionario

Eloxx Pharmaceuticals Inc Borsa (ELOX) Ultime notizie

Invus-led group holds 9.99% of Eloxx (ELOX) via shares and warrants - Stock Titan

ELOX Technical Analysis & ETF Price Forecast - Intellectia AI

symbol__ Stock Quote Price and Forecast - CNN

ELOX Price Today: Eloxx Pharmaceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC

Eloxx Pharma (ELOX) Stock Analysis Report | Financials & Insights - Benzinga

Eloxx (NASDAQ: ELOX) CEO receives 328,833 performance-based stock options - Stock Titan

Eloxx Pharmaceuticals (ELOX) director receives 13,587 stock options grant - Stock Titan

Eloxx (ELOX) director Steven Rubin receives 4,018 stock options at $11 strike - Stock Titan

Eloxx (ELOX) director Stephen Webster receives stock options for 13,587 shares - Stock Titan

ELOX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

ELOX Technical Analysis & Stock Price Forecast - Intellectia AI

ELOX PE Ratio & Valuation, Is ELOX Overvalued - Intellectia AI

ELOX News & Events - Intellectia AI

ELOX Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI

Eloxx Pharmaceuticals, Inc.(NasdaqCM: ELOX) added to NASDAQ Composite Index - marketscreener.com

Form 424B4 Eloxx Pharmaceuticals, - StreetInsider

Eloxx Pharmaceuticals (ELOX) raises ~$66M via stock and pre‑funded warrants - Stock Titan

Eloxx Pharmaceuticals Offering Expected to Close June 10 >ELOX - Moomoo

Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering - Pharmaceutical Executive

[EFFECT] Eloxx Pharmaceuticals, Inc. SEC Filing - Stock Titan

Eloxx Pharmaceuticals prices $66.0 million offering, uplists to Nasdaq - scanx.trade

Eloxx Pharmaceuticals: Shares Expected to Start Trading on Nasdaq Capital Market on June 9 >ELOX - Moomoo

Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq - PR Newswire

Eloxx Pharmaceuticals Inc (ELOXD) Stock PDF (Updated: 2026/06/06) - GuruFocus

ELOX SEC FilingsEloxx Pharmaceut 10-K, 10-Q, 8-K Forms - Stock Titan

Domicilium files Schedule 13G/A reporting 4.9% stake in Eloxx (NASDAQ: ELOX) - Stock Titan

Domicilium Real Estate Fund III LP (ELOX) swaps 1.25M shares for pre-funded warrants - Stock Titan

Total debt per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Working capital per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Book value per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Return on invested capital % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

EBITDA per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Free cash flow per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Debt to equity ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Net current asset value per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Asset turnover of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Operating cash flow per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Long term debt to total assets ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

CapEx per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Long term debt to total equity ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Debt to assets ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Return on assets % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Price to cash flow ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

EBIT per share of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Enterprise value of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Eloxx Pharmaceuticals, Inc. Statistics – OTC:ELOXD - TradingView

Enterprise value to EBITDA ratio of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

EBITDA margin % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Total liabilities of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Net margin % of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Total debt of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Free float of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Basic earnings per share (basic EPS) of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Non-operating income (total) of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

EBIT of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Non-controlling/minority interest of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Cash from financing activities of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Pretax income of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Cash from investing activities of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Net income before discontinued operations of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Diluted net income available to common stockholders of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Operating expenses (excl. COGS) of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Operating income of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Eloxx Pharmaceuticals, Inc. Cash Flow – OTC:ELOXD - TradingView

Dilution adjustment of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Taxes of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Total operating expenses of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Total revenue of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Gross profit of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Preferred dividends of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

EBITDA of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Average basic shares outstanding of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

After tax other income/expense of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

Diluted earnings per share (diluted EPS) of Eloxx Pharmaceuticals, Inc. – OTC:ELOXD - TradingView

ROIV

$30.41

1.27%

MRNA

$55.40

6.27%

BNTX

$89.50

1.43%

RPRX

$54.21

0.11%

ONC

$263.92

1.60%

RVMD

$156.58

2.17%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters